International

Pharmatech Oncology has developed strategic collaborations with sites in Hong Kong and Eastern Europe. Through these relationships, we can significantly increase the number of potential study subjects, especially in smaller indications or non-standard-of-care treatment options in the US. Sponsors can select to work with these sites directly, or have Pharmatech Oncology manage the international component of your studies.